Alan Seth Krasner, Chief Medical Officer at Crinetics Pharmaceuticals, Inc. (CRNX), bought 2,000 shares at $17.00 ($34K) on 2018-07-20, disclosed to the SEC on 2018-07-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| BIOD | SELL | 2012-11-05 | $10K | — | Filing → |
| BIOD | SELL | 2011-09-22 | $5K | — | Filing → |